The role of the gut microbiome in metabolic diseases, such as diabetes, has emerged as a pivotal area of medical research. Wang et al.'s recent work reported that a gut bacteria-derived microbial-host isozyme, mimicking a human enzyme responsible for blood glucose regulation, can significantly impact the efficacy of diabetes medications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmet.2023.09.008 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!